脊柱MRI低T1信号骨病变的影像报告建议现状
回顾性分析538份脊柱MRI报告中椎体病变描述为「不确定」的病例,最终259个病灶符合标准。结果显示77%的报告建议进一步评估或随访,但仅49%给出具体复查时间,且随访方式与时间差异很大。恶性肿瘤病史主要影响复查时间而非是否建议随访,目前缺乏多学科指南规范报告与管理。
要点
- 低T1信号椎体病灶报告建议高度异质,阅片时应尽量明确建议方式与具体复查时间。
- 已知恶性肿瘤者复查时间常提前至约2.9–3.4个月,无肿瘤史者约5个月。
- 17例30天内重复增强MRI发现3例恶性病灶,均见于已知或同时诊断的骨外转移者。
核心结论
- 脊柱MRI低T1信号骨病变的报告建议存在显著异质性,即使建议随访也常未提供具体时间间隔。
- 恶性肿瘤病史对是否建议随访影响不大,但使随访时间趋于提前。
- 目前缺乏标准化报告和管理的多学科指南。
研究设计与样本
- 回顾性研究,回顾了538份脊柱MRI报告中椎体病变被描述为「不确定」的病例。
- 记录报告建议和肿瘤病史,排除既往转移性骨病、明确侵袭性特征或已描述稳定的病例。
- 最终259个病灶符合纳入标准。
诊断标准与关键数值
- 77%的报告建议进一步评估或随访,其中53%建议MRI,16%建议CT,9%建议核医学检查,8%仅建议随访未说明方式,9%联合多种影像方式。
- 仅49%的报告给出具体随访时间,时间从2–4周到6–12个月不等。
- 无肿瘤史者随访建议率为76%,局限期肿瘤者84%,转移性疾病者72%。
- 无肿瘤史者平均随访时间约5个月,已知恶性肿瘤者约2.9–3.4个月。
- 17例初次平扫后在30天内重复增强MRI,发现3例恶性病变,均见于已知或同时诊断的骨外转移性疾病患者。
临床应用与阅片要点
- 阅片发现椎体低T1信号病灶时,报告中应尽量给出具体随访建议方式与时间间隔,避免仅写「建议随访」。
- 涉及恶性肿瘤病史患者时,可考虑将复查时间提前至约3个月。
- 对初次平扫可疑且临床有骨外转移背景者,短期增强MRI有助于发现恶性病变。
局限性
- 回顾性研究设计,存在报告信息与随访记录不完整的可能。
- 研究仅描述报告建议,未评估后续实际临床结局与不同建议对预后的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Low T1 signal intensity bone lesions are commonly encountered on MR imaging and lack consensus for management. This study evaluated radiology follow-up recommendations for indeterminate T1 hypointense vertebral lesions described in image reports.
METHODS: We retrospectively reviewed 538 spine MRIs in which vertebral lesions were reported as "indeterminate." Report recommendations and cancer history were recorded. Exams were excluded if there was prior metastatic bone disease, clearly aggressive features or described stability.
RESULTS: 259 lesions met study criteria. 67% had no cancer history, 22% had active or remote early stage cancer and 11% had metastatic disease. 77% of reports advised further evaluation or follow-up. 53% recommended MRI, 16% recommended CT, 9% suggested nuclear imaging and 8% advised follow-up without specifying modality. 9% invoked multiple imaging modalities for further evaluation. Only 49% gave specific follow-up timing recommendations which varied from 2-4 weeks to 6-12 months. Follow-up was recommended in 76% without known cancer, 84% with local cancer and 72% with metastatic disease. Follow-up timing trended sooner in the setting of known malignancy (2.9-3.4 months) than those without cancer (5 months). 17 cases with initial non-contrast evaluation underwent repeat contrast-enhanced MRI within 30 days. Three malignant lesions were identified, all in individuals with known or concurrently diagnosed extra-skeletal metastatic disease.
CONCLUSION: Radiology reporting of low T1 signal intensity bone lesions is very heterogenous. When lesions were mentioned, most reports recommended follow-up imaging. There was substantial variation in modality and over 50% of cases did not provide a specific follow-up interval. Malignancy history did not strongly influence the frequency of follow-up recommendation, but it did appear to influence follow-up timing. At present there are no multi-disciplinary guidelines to standardize reporting and management of low T1 signal intensity vertebral lesions.
引用
- Barkovich, Mehan, Buch, et al. Radiology Reporting Trends for Indeterminate Low T1 Signal Intensity Bone Lesions Described on Spine MRI. AJNR Am J Neuroradiol. 2026. PMID: 42735922. doi:10.3174/ajnr.A9636
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。